Home
Resources
Follow portfolio news
...

BluWave names Cressey & Company in the top 2% of most innovative private equity managers in the U.S.

Published on
20/5/2025
Amended on
6/11/2026
0
minute(s)
Odyssey 2022
Cressey
Cressey & Company, Fund manager in the Vintage FPCI Altaroc Odyssey , has been named to the “Top Private Equity Innovator Award 2025” ranking, organized by the expert platform BluWave. This distinction ranks the Chicago-based firm among the top 2% of the most innovative private equity firms in the most dynamic and competitive market: North America.
By
Antoine Orsoni
Antoine Orsoni
BluWave names Cressey & Company in the top 2% of most innovative private equity managers in the U.S.
This article has been automatically translated. Please excuse any inaccuracies or translation errors.
Dieser Artikel wurde automatisch übersetzt. Bitte entschuldigen Sie etwaige Ungenauigkeiten oder Übersetzungsfehler.
This article has been automatically translated. We apologize per inaccuracies or translation errors.

Award: Cressey & Company by BluWave as One of the World's Leading Private Equity Firms

This prestigious recognition highlights Cressey & Company ’s excellence in implementing distinctive practices in the areas of due diligence proactive management, value creation, modern internal operations, and corporate culture.

The rigorous and independent selection process for this ranking evaluated more than 6,000 private equity firms worldwide based on 75 specific criteria and more than 400,000 data points, in close consultation with institutional investors, investment bankers, and industry experts.

This evaluation framework aligns perfectly with BluWave’s DNA—an expert platform that connects private equity firms with specialized service providers to accelerate value creation and optimize the due diligence , and professionalize the operations of portfolio companies.

BluWave's Evaluation Criteria and Methodology

To be included in this very select group representing the industry’s elite, BluWave’s criteria are based on four key pillars of operational performance:

  • Due Diligence : Assessing the Fund manager ability Fund manager identify risks and growth opportunities well before the acquisition agreement is signed, using exclusive industry databases.
  • The Value Creation : An assessment of the tools made available to management teams to accelerate digital transformation, optimize supply chains, and recruit key talent.
  • Modern Internal Operations: An analysis of the fund’s internal structure, including its use of cutting-edge technologies and cloud architectures to manage its own performance.
  • Corporate Culture: Assessment of human resources practices, the stability of management teams, and the alignment of interests with the founders of partner companies.

A unique position among the top 2% in the industry

Founded more than 40 years ago (building on the legacy of its pioneering founders), Cressey & Company is one of the first specialized private equity firms to emerge in the United States. The firm focuses exclusively on two interconnected sectors: healthcare and healthcare information technology (Healthcare IT).

With $3.7 billion in assets under management, the firm has established successful partnerships with more than 35 companies. Compared to other managers in this top 2%—who are often generalists or diversified— Cressey & Company for its ultra-specialization. While massive funds deploy broad strategies, Cressey takes a surgical approach summarized by its three guiding principles: “Target, Partner, Build.”

The "Target, Partner, Build" Approach in Practice

  1. Target: Identify high-potential niches within an increasingly complex healthcare system.
  2. Partner (Partnering): Work closely with experienced management teams while allowing them operational autonomy.
  3. Build: To build innovative, sustainable companies that meet the most stringent clinical and regulatory requirements.

A Real-World Example of Value Creation: The Convergence of Healthcare and Technology

The most compelling example of this strategy is Cressey's long-standing investments in platforms such as Homecare Homebase. This company develops decision-support and management software solutions for home care and hospice agencies.

Working alongside the management team, Cressey & Company and structured the large-scale technology rollout of the platform. This transformation made it possible to:

  • To automate the tracking of clinical records for patients at home.
  • To optimize the schedules of nurses and other healthcare staff in the field.
  • To ensure billing and compliance with U.S. health insurance systems (Medicare).

Thanks to this operational support, the company has expanded its customer base and established itself as the technology leader in its sector, perfectly illustrating how an infusion of capital and expertise can transform a regional company into a national champion.

Check out the interview with David Rogero | Cressey & Company

The Perspective of Institutional Investors

Cressey & Company 's model offers the transparency and stability that are particularly sought after by large institutional investors (pension funds, insurers, sovereign wealth funds) that allocate capital to private equity.

Market analyses conducted by industry experts highlight that Cressey's ability to generate strong performance is not based on financial leverage, but on genuine improvements in operations and the quality of care at the clinics, laboratories, and medical software companies it supports.

Ranking Trends: The Reward for Operational Excellence

An analysis of this ranking over the past few years reveals a very clear underlying trend: the private equity market has definitively shifted. Previously, funds were primarily recognized for their financial engineering or the size of their fundraising rounds.

Today, evaluation frameworks such as BluWave’s primarily reward managers who are capable of bringing about tangible change in companies. In a more challenging global economic environment, it is specialized firms—those with strong in-house operational teams and the ability to forge long-term strategic partnerships—that are securing lasting positions at the top of global rankings.

Other content in this topic

Explore our content collections, which bring together different formats around a single subject/issue/theme.
Follow portfolio news
News from the Vintage Altaroc Companies
Every two weeks, check out the latest announcements from the Vintage Altaroc companies.
Article
|
04
2026-11-04
News from the Vintage Altaroc Companies
Follow portfolio news
News from the Vintage Altaroc Companies
Every two weeks, check out the latest announcements from the Vintage Altaroc companies.
Article
|
22
2026-10-22
From elite sports to medical AI: what's new in the portfolio Altaroc
Follow portfolio news
From elite sports to medical AI: what's new in the portfolio Altaroc
Software adopted by every NFL team, AI agents that have already conducted 180 million interactions with patients, and a platform used by nearly one in five Fortune 500 companies. A look at nine acquisitions by the " Vintage "Odyssey over the past three months.
Article
|
19
2026-10-19
Follow portfolio news
News from the Vintage Altaroc Companies
Every two weeks, check out the latest announcements from the Vintage Altaroc companies.
Article
|
08
2026-10-08
A triptych illustrating the sports, health, and business sectors for corporate news from Vintage Altaroc
Follow portfolio news
News from the Vintage Altaroc Companies
Every two weeks, check out the latest announcements from the Vintage Altaroc companies.
Article
|
23
2026-09-23
Interview with Raul Villar, CEO of Optro
Follow portfolio news
Interview with Raul Villar, CEO of Optro
Raul Villar Jr. unveils his platform's global growth strategy, powered by AI, and his partnership with Hg
Video
|
13
2026-08-13
Interview with Chris Maclin, CEO of Empyrean
Follow portfolio news
Interview with Chris Maclin, CEO of Empyrean
In Boston, Chris Maclin, CEO of Empyrean, explains how his technology platform protects banks and modernizes risk management
Video
|
29
2026-05-29
Interview with Ian Drysdale, CEO of One Inc.
Follow portfolio news
Interview with Ian Drysdale, CEO of One Inc.
Learn about the career of Ian Drysdale, CEO of One Inc, a specialist in payment infrastructure for the insurance industry.
Video
|
09
2026-04-09
Interview with Daniel Baker, CEO of Healthdrive
Follow portfolio news
Interview with Daniel Baker, CEO of Healthdrive
In Boston, Daniel Baker, CEO of HealthDrive, shares his vision for sustainable growth with a human impact.
Video
|
29
2026-01-29
Interview Jeff Wessler - CEO Heartbeat
Follow portfolio news
Interview Jeff Wessler - CEO Heartbeat
Dr. Jeff Wessler, founder of Heartbeat Health, pioneer of virtual-first cardiology in the United States
Video
|
25
2025-11-25
Special report - Focus on the United States: 10 hypergrowth companies
Follow portfolio news
Special report - Focus on the United States: 10 hypergrowth companies
As the historic driving force behind global private equity, the United States is home to some of the most dynamic companies on the planet. This report highlights 10 hyper-growth American companies, backed by private equity, at the heart of key economic sectors.
File
|
12
2024-03-12
No articles in this category yet.
Welcome to Altaroc
In accordance with applicable regulations, we ask that you complete your profile. This step is required to access the content and services offered on our websites.
Please fill out your profile to access the site
country of tax residence
Select
choosenCountry
Preferred language
Select
choosenLang
YOUR INVESTOR PROFILE
Financial intermediary or professional investor
Financial advisors, wealth managers, private bankers, or any other investment service providers.
Qualified Investor or Altaroc Investor
Experienced investor or Altaroc investor
Private investors who have already invested with Altaroc or who have a minimum investment capacity of €100,000.
Private investors who have previously invested in Altaroc who have a minimum investment capacity of 200,000 euros.
Non-professional (retail) investor
Individual investors with an investment capacity below €100,000.
Retail investors with an investment capacity of less than 200,000 euros.
Institutional investor
Pension funds, retirement schemes, asset management companies, and single-family offices.
Select your language and investor profile to continue
Select your investor profile to continue
Scroll down to accept General Terms and Conditions
The webpage you are trying to access is not available in your country.